Cargando…
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) driven by oncogenic K-Ras remains among the most lethal human cancers despite recent advances in modern medicine. The pathogenesis of PDAC is partly attributable to intrinsic chromosome instability and extrinsic inflammation activation. However, the molecular...
Autores principales: | Kang, Rui, Xie, Yangchun, Zhang, Qiuhong, Hou, Wen, Jiang, Qingping, Zhu, Shan, Liu, Jinbao, Zeng, Dexing, Wang, Haichao, Bartlett, David L, Billiar, Timothy R, Zeh, Herbert J, Lotze, Michael T, Tang, Daolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518983/ https://www.ncbi.nlm.nih.gov/pubmed/28374746 http://dx.doi.org/10.1038/cr.2017.51 |
Ejemplares similares
-
HMGB1 as a potential biomarker and therapeutic target for severe COVID-19
por: Chen, Ruochan, et al.
Publicado: (2020) -
PKM2 Regulates the Warburg Effect and Promotes HMGB1 Release in Sepsis
por: Yang, Liangchun, et al.
Publicado: (2014) -
Novel chemokine-like activities of histones in tumor metastasis
por: Chen, Ruochan, et al.
Publicado: (2016) -
Endogenous HMGB1 regulates autophagy
por: Tang, Daolin, et al.
Publicado: (2010) -
cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis
por: Chen, Ruochan, et al.
Publicado: (2019)